-
June 6, 2016 Lupin Receives FDA Approvals for Generic Vfend® Tablets 50mg, 200mg & Vfend® Oral Suspension, 40 mg/mL
-
May 26, 2016 Lupin announces closure of US FDA Audits for its Mandideep and Aurangabad Facilities
-
May 19, 2016 Record Sales & Profits – A New High Quarter IV & Annual Results – FY2016 Q4 FY2016 Net Sales up 34.0%, EBITDA up 72.7%, Net profit up 47.5% Proposed Dividend 375%
-
April 18, 2016 Lupin Launches Generic Femhrt® Tablets in the US
-
April 11, 2016 Lupin to Market new Inhaler under the brand name Loftair® in India
-
April 5, 2016 Lupin Launches Generic Intermezzo® Sublingual Tablets in the US
-
April 5, 2016 Lupin Appoints Dr. Kurt Nielsen as President of Lupin – Somerset
-
April 5, 2016 Lupin named amongst AON Best Employers India 2016
-
March 31, 2016 Lupin launches Generic Aricept tablets in the US
In this section
Media Contacts
-
Rajalakshmi Azariah
Vice President & Global Head – Corporate Communications